Bobst Group has successfully completed its issuance of CHF 200,000,000 senior unsecured bonds with a maturity date in 2029 and a coupon of 2.545%. The bonds will be listed on the SIX Swiss Exchange. UBS Investment Bank, BNP
Tags :Hubertus Hillerström
JBF Finance and Bobst Group signed a CHF 419,500,000 term loan and revolving credit facilities with UBS Switzerland and Credit Suisse (Switzerland) as original lenders and arrangers aimed at refinancing the bridge facilities granted to JBF
Walder Wyss advised UBS Switzerland as mandated lead arranger, underwriter and fronting bank on a syndicated credit facilites agreement for Groupe Baume to finance the acquisition of certain participations in the companies of the group
A consortium of investors, advised by Union Bancaire Privée (UBP) and The Risk Management Group (RMG), has entered into a sale and leaseback transaction with the owners of Hôpital de La Tour in
Token Flow Insights has completed the first close of its Series A financing round with USD 12 million raised to date to expand our unique state processing technology that takes blockchain data analytics to a whole
A private family office has acquired the whole outstanding share capital of Qcenter from SR Fund I. The fund was initiated and managed by Swissroc Investment and comprising a handful of local entrepreneurs. The private
Usr Unité de Secours Régional, a company in the field of rescue, medical transfers and the provision of paramedical services in the canton of Vaud. As of 28 March 2022, became part of TCS Swiss Ambulance
The banking group J. Safra Sarasin, sustainable private bank, has acquired the 15,000 sqm landmark real property located at Place de Hollande in Geneva from BNP Paribas (Suisse) for an amount of approximately CHF 270 million in
idverde group, specialists in the creation and landscaping of green spaces with more than 8’000 employees and branches in France, the United Kingdom, the Netherlands, Denmark and Germany, is now extending its activities to Switzerland where
Walder Wyss has acted as advisor to Sleepiz in the completion of its CHF 4.4 million Series A financing round. The newly raised capital will support Sleepiz expansion of its portfolio to chronic respiratory disease monitoring.